Overview
Lasa Supergenerics Limited is engaged in manufacturing, trading, and producing chemicals, pharmaceuticals, and veterinary APIs, with comprehensive capabilities in research, production, and marketing.
The company specializes in catalyst chemistry and is among India's largest producers of anthelmintic and veterinary API products, with significant production capacity at its facilities in Maharashtra.
Lasa's strategic amalgamation with Harishree Aromatics and Chemicals Pvt. Ltd. strengthens its manufacturing capabilities and market reach, approved by the National Company Law Tribunal in late 2022.
The company has launched two new high-demand veterinary products and is expanding capacity at its Chiplun unit, aiming to capture significant market share globally.
With a WHO Certificate of Good Manufacturing Practices, Lasa is positioned as a key player in the animal healthcare sector with robust global alliances.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
42 Cr
- Volatility
Low Risk
- P/E Ratio
-1.0
- Industry P/E
34.2
- PEG Ratio
5.2
- P/B Ratio
0.7
- 52W High
19.65
- 52W Low
5.65
Financial Ratios
Sales CAGR
- 1Y
- 36.52%
- 3Y
- 1.28%
- 5Y
- -3.16%
- 10Y
- —
Profit CAGR
- 1Y
- 32.08%
- 3Y
- —
- 5Y
- —
- 10Y
- —
ROE
- TTM
- 0.87%
- 3Y
- -25.15%
- 5Y
- -9.37%
- 10Y
- -4.87%
ROCE
- TTM
- -11.71%
- 3Y
- -23.41%
- 5Y
- -7.29%
- 10Y
- -0.09%
Technicals
Oscillators
Neutral
Bearish
3
Neutral
7
Bullish
4
Overall
Bullish
Bearish
10
Neutral
7
Bullish
29
Moving Averages
Bullish
Bearish
7
Neutral
0
Bullish
25
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
